In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn BPC 157 Explained: Benefits, Safety & Oral vs Injectable Options The Amino zing World of Peptide Regulation ArentFox Schiff FDA to weigh easing limits on unproven peptides promoted by RFK Jr.